lung cancer
Conditions
Interventions
Trail group:None
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1)pathologically confirmed stage I-IV lung cancer; (2)age >18 years old; (3)results of second-generation sequencing tests of tissue or blood sample (4)complete epidemiological data; (5)regular tumor evaluation.
Exclusion criteria
Exclusion criteria: (1) Combination of other tumors (2) Severe organ insufficiency (3) missing data or impossible contact.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prevalence of G719X and S768I mutations of EGFR gene; | — |
Secondary
| Measure | Time frame |
|---|---|
| prevalence of other rare mutations of EGFR gene;prevalence of common drive mutations of EGFR gene; | — |
Countries
China
Contacts
Public ContactJun She
Zhongshan Hospital, Fudan University
Outcome results
None listed